Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Type 2 Diabetics
Status:
Completed
Trial end date:
2020-08-31
Target enrollment:
Participant gender:
Summary
The purpose of the EmDia trial is to compare the effects of empagliflozin with placebo in
addition to standard diabetic treatment or dietetic treatment on cardiac diastolic function
in patients with type 2 Diabetes mellitus.